BPL Medical Technologies’ AI & Digital Health Push: Building an Integrated MedTech Ecosystem

BPL Medical Technologies is expanding beyond conventional medical equipment to build an integrated healthcare technology ecosystem combining medical devices, software, artificial intelligence (AI), clinical data and digital workflows, according to Guruswamy Krishnamoorthy, CEO, BPL Medical Technologies. The company is focusing on advanced imaging, critical care, respiratory diagnostics, patient monitoring and connected digital health solutions as key growth areas for India’s evolving MedTech sector.

Tailoring Healthcare Technology for Tier 1, 2 and 3 Cities

BPL’s strategy includes developing market-specific healthcare technology portfolios for Tier 1, Tier 2 and Tier 3 cities, where hospitals increasingly require solutions that balance advanced clinical capabilities with affordability. The company has also strengthened its respiratory diagnostics portfolio through a partnership with Jaeger Medical and recently launched the BPL Vent 300, a critical-care ventilator capable of providing invasive ventilation, non-invasive ventilation (NIV) and high-flow nasal cannula (HFNC) therapy for adult, paediatric and infant patients on a single platform.  Explore the BPL Vent 300

Expanding into Preventive Diagnostics with Yozma BMTech

The company has also expanded into preventive diagnostics following its acquisition of South Korea-based Yozma BMTech, entering the bone densitometry segment. The acquisition aligns with BPL’s focus on preventive healthcare, chronic disease monitoring and technologies supporting women’s health, particularly bone-health assessment.

BPL Cortex: Powering AI-Enabled Digital Health

Digital transformation remains central to the company’s growth strategy. Through BPL Cortex, its digital health platform, the company is integrating medical devices, clinical data, AI-enabled insights and workflows to support faster clinical decision-making. BPL said its approach to AI is designed to be assistive, ethical, explainable and auditable, with continuous performance monitoring and governance mechanisms.  Learn more about BPL Cortex

India’s MedTech Import Dependence: The Opportunity for Indigenous Innovation

India’s medical device sector continues to face significant import dependence, particularly in high-end equipment. A 2026 CareEdge assessment of BPL Medical Technologies noted that approximately 75–80% of medical devices in India are currently imported, highlighting the substantial opportunity for domestic manufacturing and innovation.

Beyond Import Substitution: Building Globally Competitive MedTech from India

Krishnamoorthy said India’s MedTech opportunity extends beyond simply replacing imported products. The next phase, he noted, will depend on developing globally competitive technologies from India that combine innovation, affordability and clinical relevance. With India’s talent pool, healthcare scale and clinical expertise, domestic companies have an opportunity to develop and export advanced healthcare solutions while improving access to quality care within the country.About BPL Medical Technologies